{"id":"NCT01731600","sponsor":"Novo Nordisk A/S","briefTitle":"A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A","officialTitle":"A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-02-20","primaryCompletion":"2014-09-15","completion":"2018-09-28","firstPosted":"2012-11-22","resultsPosted":"2019-10-30","lastUpdate":"2020-11-23"},"enrollment":68,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Congenital Bleeding Disorder","Haemophilia A"],"interventions":[{"type":"DRUG","name":"turoctocog alfa pegol","otherNames":["NNC 0129-0000-1003","N8-GP"]}],"arms":[{"label":"N8-GP","type":"EXPERIMENTAL"}],"summary":"This trial is conducted globally. The aim of the trial is to investigate safety, efficacy and pharmacokinetics (the exposure of the trial drug in the body) of NNC 0129-0000-1003 (N8-GP) in children with severe haemophilia A who have undergone treatment with previous factor VIII (FVIII) products.","primaryOutcome":{"measure":"Number of Participants With Inhibitory Antibodies Against Coagulation Factor VIII (FVIII) ≥0.6 Bethesda Units","timeFrame":"During the main phase of the trial (from 0-26 weeks of treatment)","effectByArm":[{"arm":"Younger Children (0 - 5 Years) [Main Trial]","deltaMin":0,"sd":null},{"arm":"Older Children (6 - 11 Years) [Main Trial]","deltaMin":0,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"0 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":51,"countries":["United States","Brazil","Canada","France","Greece","Israel","Italy","Japan","Lithuania","Malaysia","Portugal","Puerto Rico","Switzerland","Turkey (Türkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["32293786","32940955"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":34},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Cough","Gastroenteritis","Headache"]}}